Pancreatic Cancer Cell Genetics and Signaling Response to Treatment Correlate with Efficacy of Gemcitabine-Based Molecular Targeting Strategies

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

Medicine, Oncology, Pharmacotherapy +16

Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators

Taylor A. Sohn, Charles J. Yeo, John L. Cameron et al. · Journal of Gastrointestinal Surgery · 2000 · 1.5K citations

Medicine, Oncology, Surgery +12

Control of IκB-α Proteolysis by Site-Specific, Signal-Induced Phosphorylation

Keith Brown, Susan M. Gerstberger, Louise Carlson et al. · Science · 1995 · 1.4K citations

Life Sciences, Biochemistry, Molecular Biology +13

Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 Patients

Charles J. Yeo, John L. Cameron, Keith D. Lillemoe et al. · Annals of Surgery · 1995 · 950 citations

Medicine, Oncology, Surgery +15

Role of NF-κB and Akt/PI3K in the resistance of pancreatic carcinoma cell lines against gemcitabine-induced cell death

Alexander Arlt, André Gehrz, Susanne Sebens Müerköster et al. · Oncogene · 2003 · 473 citations

Medicine, Cell Biology, Oncology +14